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Retinoicacid(RA)triggersphysiologicalprocessesbyactivatingheterodimerictranscriptionfactors
(TFs) comprising retinoic acid receptor (RARa, b, c) and retinoid X receptor (RXRa, b, c). How a
single signal induces highly complex temporally controlled networks that ultimately orchestrate
physiological processes is unclear. Using an RA-inducible differentiation model, we deﬁned the
temporalchangesinthegenome-widebindingpatternsofRARcandRXRaandcorrelatedthemwith
transcription regulation. Unexpectedly, both receptors displayed a highly dynamic binding, with
different RXRa heterodimers targeting identical loci. Comparison of RARc and RXRa co-binding at
RA-regulated genes identiﬁed putative RXRa–RARc target genes that were validated with subtype-
selective agonists. Gene-regulatory decisions during differentiation were inferred from TF-target
gene information and temporal gene expression. This analysis revealed six distinct co-expression
paths of which RXRa–RARc is associated with transcription activation, while Sox2 and Egr1 were
predicted to regulate repression. Finally, RXRa–RARc regulatory networks were reconstructed
through integration of functional co-citations. Our analysis provides a dynamic view of RA
signalling during cell differentiation, reveals RAR heterodimer dynamics and promiscuity, and
predicts decisions that diversify the RA signal into distinct gene-regulatory programs.
Molecular Systems Biology 7: 538; published online 11 October 2011; doi:10.1038/msb.2011.73
Subject Categories: functional genomics; signal transduction
Keywords: ChIP-seq; retinoic acid-induced differentiation; RXR–RAR heterodimers; temporal control of
gene networks; transcriptomics
Introduction
Retinoicacidreceptors(RARs)andretinoidXreceptors(RXRs)
are members of the nuclear receptor (NR) gene family of
ligand-regulated transcription factors (TFs). RARs and RXRs
form heterodimers that act as master regulators for multiple
physiological processes, including embryogenesis, organo-
genesis, immune functions, reproduction, and organ homeo-
stasis (Mark et al, 2006). Apart from their impact on
physiology, RARs and RXRs have major promise for therapy
and prevention of cancer and other diseases, and several
therapeutic paradigms have been established (Altucci et al,
2007; Liby et al, 2007; Shankaranarayanan et al, 2009;
de The and Chen, 2010; Zhang et al, 2010).
The biological importance of the retinoid signalling system
and its cancer therapeutic potential has inspired intense
research that provided detailed insight in the structural
basis of, and molecular events at the early steps of retinoid
action. Mechanistically, the binding of a ligand facilitates
the exchange between corepressor (CoR) and co-activator
(CoA) complexes by allosterically altering receptor surfaces
involved in these interactions. The recruitment of such
epigenetically active and/or chromatin modifying complexes
leads to chromatin structure alterations and post-translational
modiﬁcations that ultimately regulate cognate gene programs
(Gronemeyer et al, 2004; Rosenfeld et al, 2006).
The retinoid signalling system is highly complex, as it
comprises three RXR (RARa, b and g) and three RAR (RARa,
b and g) subtypes expressed from distinct genes as multiple
isoforms which act as heterodimers; in addition, RXRs can
form heterodimers with a plethora of other NRs (Laudet and
Gronemeyer, 2002). While insight into (some of) the physio-
logical functions of the various RAR and RXR subtypes has
been obtained by exploiting mouse genetics (Mark et al,
2006) our understanding of the cell physiological functions
of these various subtypes is rather limited. The generation
of subtype-selective ligands has provided important tools
(de Lera et al, 2007), while the study of RAR subtype-deﬁcient
F9 embryonal carcinoma (EC) cells (Su and Gudas, 2008),
despite its values, has been hampered by the observation of
artifactual ligand responsiveness of the expressed RAR
subtypes. Thus, we are presently facing a situation in which
signiﬁcant knowledge has been accumulated about the very
early steps in retinoid action and the (patho)physiological
impact of RAR and RXR signalling. However, what has
remained entirely enigmatic is how a single compound upon
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the temporal order of complex signalling networks that are
at the basis of (patho)physiological phenomena.
Knowledge about the early events in retinoid signalling has
been derived mainly from in vitro models like F9 EC cells,
which differentiate into primary endodermal-like cells upon
exposure to all-trans retinoic acid (ATRA); this differentiation
is well characterized by morphological changes and marker
expression. F9 cells display a very low rate of spontaneous
differentiation, such that homogeneous cell populations can
be generated during ATRA-induced differentiation. Previous
studies demonstrated that, while different RXR–RAR isotype
combinations control the expression of different target genes,
the RXRa–RARg heterodimer is essential for inducing differ-
entiation (Taneja et al, 1996; Chiba et al, 1997a,b). Together,
these data support a model in which various RXR–RAR
heterodimers regulate subtype-selective gene programs, of
which RXR–RARg establishes a path that leads to the changes
which specify a differentiated F9 cell.
Here, we have addressed the question of how RXRa RARg
upon activation by ATRA sets up a sequence of temporally
controlled events that generate different subsets of primary
andsecondarilyinduced gene networks.Wehypothesizedthat
these networks required temporally deﬁned step(s) of diversi-
ﬁcation, thereby forming separable gene cohorts that consti-
tute the various facets of differentiation, such as altered
proliferation, cell physiology, signalling, and ﬁnally terminal
apoptogenic differentiation. To this aim, we performed RARg
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Cell differentiation was studied over 48h after ATRA induction by establishing dynamic transcriptomics and ChIP-seq proﬁlings to correlate genome-wide RXRa
and RARg chromatin binding patterns with gene expression. RXRa and RARg metaproﬁles, constructed from the cumulation of ChIP-seq patterns at all time
points (0, 2, 6, 24, and 48h) were instrumental for curation of the spatio-temporal binding information before integration of transcriptomics data. Combined data
setswereusedfortheidentiﬁcationofputativeRXRa–RARgtargetgenes.Inaddition,theinformationobtainedfromtemporaltranscriptomicsdatasetsgenerated
with RAR isotype-selective agonists were incorporated in the analysis. The temporal transcription regulation information, the RXRa–RARg direct target
annotations and presently available TF binding site annotations were integrated into the Dynamic Regulatory Events Miner (DREM) to identify decision points that
deﬁneaco-expressionregulatorymapandpredictedTF-basedkeydecisionsthatleadtothetemporalestablishmentofsubprogramsduringdifferentiation.Finally,
this dynamic regulatory map enabled the reconstruction of an RXRa–RARg signalling network from functional co-citations. t*h, transcriptome at time point*h; p*h,
chromatin binding at time-point*h; TF, transcription factor.
Box 1 Integrative ‘omics’ approach to construct the dynamic RXRa–RARg signalling network during ATRA-induced F9
cell differentiation.
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coupled with massive parallel sequencing (ChIP-seq) together
with the corresponding microarray transcriptomics at ﬁve
time points during differentiation (Box 1). To understand the
dynamics of ATRA-regulated gene expression during differ-
entiation, gene-regulatory decisions were inferred in silico
from characterized targets of RXRa RARg and other anno-
tated TFs (Ernst et al, 2007). This dynamic regulatory map
was used to reconstruct RXRa–RARg signalling networks by
integration of functional co-citation. Altogether, we present
a genome-wide view of the temporal gene-regulatory events
elicited by the RXRa–RARg during F9 cell differentiation.
Results
Genome-wide characterization of RXRa-RARc
binding sites during ATRA-induced F9 cell
differentiation
We ﬁrst conﬁrmed the induction of markers (Rarb, Hoxa1,
and Col4a1) for F9 cell differentiation by RT–PCR (Supple-
mentary Figure S1A) and the detection of binding at previ-
ously described RAREs in the Cyp26a1 promoter (Loudig
et al, 2000, 2005) using anti-RXRa antibodies (R1 and R2 in
Supplementary Figure S1B and C). As expected, these sites
were empty in F9 cells lacking RXRa (Rxra
 / ).
We reasonedthat combining uniquelyaligned reads fromall
ChIP-seq time points (0, 2, 6, 24, and 48h) would generate a
valuable meta binding site proﬁle for subsequent analyses, as
it (i) cumulates all stable and transient binding events over the
48-h period and (ii) increases the peak calling conﬁdence due
to the combination of ﬁve data sets. Therefore, uniquely
aligned reads from the RXRa and RARg ChIP-seqs at different
time points were combined and processed (see Materials and
methods) to generate the corresponding metaproﬁles.
To identify chromatin sites occupied by RXRa–RARg hetero-
dimers, binding sites for the two receptors in the metaproﬁles
were compared at different P-value thresholds and the percentage
of co-occupancy was plotted for each receptor (Figure 1A). This
analysis identiﬁed an optimal conﬁdence threshold (CT40;
P-value 10
 4) for which all 4281 identiﬁed RARg meta sites
were co-occupied by RXRa. For the same CT RXRa bound
to 9065 additional sites, most likely as heterodimer with
partner(s) other than RARg. Note that the implication of other
RXRa heterodimers in ATRA-induced F9 cell differentiation
has been reported (Chiba et al, 1997a).
Highly dynamic binding of RXRa–RARc during
differentiation
Temporal analysis of RXRa and RARg at its 4281 meta binding
sites revealed a highly dynamic binding (Supplementary
Figure S2). In absence of ATRA, 2158 of the meta binding
sites were co-occupied by RXRa and RARg. Two hours later,
1124 additional meta sites were occupied by the heterodimer,
thus increasing the number of co-occupied sites; a similar
addition of new heterodimer binding sites was observed at
later time points, albeit with decreasing tendency (Figure 1B).
Importantly, the numberof RARg–RXRa binding sites decreased
when cells moved through the differentiation program from
initially B2000 sites at 0h to o1000 sites at 48h. At 2 and 6h,
the gain in heterodimer binding compensated the loss of
sites present at 0h, while after 6h there was an overall loss
of RXRa–RARg binding and at 48h only 814 were observed.
A similar loss was observed for the number of sites that were
newly added at a given time point and decreased thereafter.
The observed decrease of RARg–RXRa binding sites during
differentiation could be due to (i) dissociation of both
heterodimer subunits or (ii) replacement of the RXRa–RARg
byanother RXR heterodimer. Monitoring the fraction of RXRa-
bound sites to which RARg is bound revealed that exposure to
ATRAsigniﬁcantlydecreasedRARgco-bindingtoRXRa-bound
sites over time (Figure 1C). An example is the binding of the
RARg–RXRa heterodimer to the well-known RARE of the Rarb
promoter for which the level of RARg binding decreases over
time while RXRa binding is maintained, if not increased
(Figure 1D). Most importantly, reChIP experiments, in which
RARg or RARa is immunoprecipitated from the RXRa ChIP,
demonstrated an unexpected strong increase of RARa co-
occupancy at 48h which was not observed at earlier time
points (Figure 1E and F). Note the Rarg
 /  and Rara
 /  F9 cell
control ChIPs, which reveal the background of the assay.
Together, the above data give not only a global view of
the chromatin binding dynamics of the RXRa–RARg hetero-
dimer but also provide moreover evidence for its replace-
ment during F9 cell differentiation by RXRa heterodimers
with other partners at common response elements. At present,
we cannot distinguish between swapping of RXRa partners,
i.e., dissociation followed by the formation of a distinct RXRa
heterodimer, and the replacement of RXRa–RARg by other
pre-formed RXRa heterodimers.
RXRa–RARc co-occupancy correlates with gene
induction while gene repression is largely
independent of this heterodimer
Transcription proﬁling using microarrays performed at the
same time points as ChIP-seqs revealed a biphasic global gene
induction with peaks at 2 and 48h, reminiscent of results
obtained by co-exposure to ATRA and cAMP (Harris and
Childs, 2002). Indeed, 2h after ATRA induction 281 genes
exhibited an induction of X1.8-fold relative to 0h, followed
by a progressive decline until 24h (6h, 189 genes; 24h, 128
genes; Figure 2A). In contrast, a strong ‘wave’ of gene induc-
tion was apparent at 48h, with 926 genes getting induced.
When comparing the differential gene expression with the
location of RXRa or RARg inferred from the metaproﬁles we
found that 450% of the genes induced during the ﬁrst 24h
presentedanRXRaorofRXRa–RARgsitewithin10kbdistance
(referred to as ‘putative target genes’). Similarly as for the
oestrogen receptor (Carroll et al, 2005, 2006), B70% of RXRa
(heterodimer)binding sites arebeyondthis distance at all time
points and may regulate non-annotated transcripts, such as
ncRNAs, or cognate targets through chromosomal looping
(Supplementary Figure S1D and E). At 48h, the fraction of
genes with RXRa/RXRa–RARg sites dropped to 34% of all
induced genes. This reveals that the majority of gene induc-
tions at this time are due to secondary responses. Less than
10% of the downregulated genes presented a proximal RXRa
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functions predominantly as positive regulator of transcription
in this context.
A comparison of induced mRNA levels and gene-proximal
temporal binding of RXRa–RARg indicated a signiﬁcant corre-
lation between binding and transcription activation. Indeed,
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Figure 1 RXRa and RARg nuclear receptors present a highly dynamic binding to chromatin during ATRA-induced F9 differentiation. (A) Uniquely aligned reads
sequenced from samples associated with the different time points were combined and processed to generate a meta-binding proﬁle. The percent of RXRa and RARg
co-occupancy relative to the total number of binding sites in their corresponding metaproﬁle is illustrated for different P-value conﬁdence thresholds (CT¼ 10  log
(P-value)). The inset (Venn diagram) shows that at CT¼40 all identiﬁed RARg sites are found co-occupied with RXRa. This subset of binding sites is considered
bona ﬁde RXRa–RARg heterodimer binding sites and has been used for all further analysis. (B) The RXRa–RARg binding sites identiﬁed in (A) are illustrated in the
context of their temporal recruitment, duration of occupancy and dissociation (CT25). RXRa–RARg co-occupied sites per time point are subclassiﬁed based on their
recruitment intervals and depicted by colour coding. (C) Progressive loss of RARg but not of RXRa from chromatin binding sites during ATRA-induced differentiation.
For each time point, the fraction of RXRa–RARg co-occupied sites relative to those bound by RXRa is represented for two CT values. (D) Examples of ChIP-seq
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 /  cells treated with ATRA during 48h were used to deﬁne the background. (F) ReChIP–qPCR as in (E)
but using anti-RARa antibodies for the secondary IP; Rara
 /  cells were used as background control. In (E) and (F), the fold occupancy levels were calculated relative
to a chromatin region localized at 18kb downstream of Hoxb1, which corresponds to a ‘cold’ region.
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levelsrevealedthatat2hRXRa–RARgisboundpredominantly
to strongly induced genes (Figure 2B). At 6h, RXRa–RARg
binding is more prevalent at moderately induced genes, while
at 24 and 48h the number of binding events in gene-proximal
RXRa–RARgsiteshasdramaticallydecreasedandtheremaining
subset is progressively associated with weakly induced genes.
To further assess the connection between RXRa–RARg
binding and transcription regulation of putative target genes,
we mapped RNA Polymerase II (PolII) recruitment during
ATRA-induced F9 cell differentiation by ChIP-seq. This
analysis provided information about binding of PolII at both
Transcription Start Sites (TSSs) and gene bodies (Supplemen-
tary Figure S3). For this, the PolII binding proﬁles were
processed with POLYPHEMUS (Mendoza et al, submitted),
which entails non-linear normalization of PolII enrichment
of multiple ChIP-seq data sets. Genes presenting proximal
binding sites for RXRa–RARg were subsequently ranked by
their PolII recruitment to TSSs at a given time point relative
to 0h. Interestingly, most of the top 50 genes (Figure 2C)
presented signiﬁcant PolII enrichment in both gene body and
at the TSSs, indicative of active transcription. Furthermore,
except Cyp26a1 and Prr14 the top 10 genes are TFs, supporting
a hierarchical model of ATRA-regulated gene networks in
which RXRa–RARg induces TFs, which in turn induce their
cognate gene programs.
The spatio-temporal binding of RXRa and RARc
and target gene proﬁling reveal distinct classes
of temporally controlled gene induction patterns
To link the binding of RXRa and RARg to transcription
activation, we clustered the putative target genes by their
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using a self-organization tree algorithm (SOTA; Figure 3). This
classiﬁcation revealed the existence of four classes of genes,
which differ in the timing of heterodimer binding and gene
induction (i) early induced genes with sustained expression
over 48h; (ii) early transiently induced genes; (iii) early-late
transiently induced genes and (iv) late induced gene expres-
sion (Figure 3A and B). These classes contain several
established RXR–RARtargets,such asCyp26a1, Rarb or Hoxa1
(Supplementary Table I). Note that we found a third RXRa–
RARg binding site (R3) localized B2kb downstream of the
Cyp26a1 coding regionapart fromthedistal (R2) and proximal
(R1) RAREs and detected binding sites in genes shown to
respond to ATRA but for which no RARE is described, such as
Stra6, Stra8, Cdx1, Aqp3, Foxa2/HNF-3, and Nostrin/mDaIP2.
For each of the four classes the timing of coordinate binding
and gene activation was the distinctive feature, while no
common feature could be deﬁned for the binding of the two
receptors before or after this phase. Indeed, the B2.5-kb distal
RXRa–RARg binding site of Aquaporin (Aqp3) (Bellemere
et al, 2008; Cao et al, 2008) was co-occupied by both receptors
already in absence of ATRA, while binding of RARg was
strongly reduced at 24h and no binding of either receptor was
apparent at 48h (Figure 3C and D). In addition, co-activator
components like RAC3 and p300 were recruited to this
site at 2h and were progressively reduced at later time
points (Supplementary Figure S4). Notably, Aqp3 expression
increased even after receptors/co-activators disappeared from
the locus (Figure 3B and C; Supplementary Figure S4). As for
Apq3, RXRa–RARg occupied the putative RARE of Notch4
(Uyttendaele et al, 1998) in absence of the cognate ligand and
induced transcription from 2h on, but the loss of RARg
correlated with termination of Notch4 induction and decreas-
ing mRNA levels. In the case of Ksr1 (Wang et al, 2006),
binding of RXRa–RARg was detected at 2–6h, followed by a
short pulse of transcriptional induction around 6h, which
ceased before 24h together with the loss of receptors from
the binding site. The late induced Nostrin (Cho et al, 1999;
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Figure 3 Temporal (transcription) regulation deﬁnes distinct classes of RXRa–RARg target genes. (A) SOTA classiﬁcation of putative RXRa–RARg target genes
according to the indicated criteria for RXRa and RARg binding, co-binding and gene induction reveal four different classes: (i) early induced genes displaying sustained
expression over 48h; (ii) early but transiently induced genes; (iii) early-late transiently induced genes and (iv) late induced gene expression. Only genes that show
coordinate heterodimer binding and gene activation at least at one time point are considered. (B) Illustration of putative target genes per class. Genes in bold were
previously described as ATRA responsive. Heatmaps on the left (black-yellow gradient) give the P-value conﬁdence for RXRa and RARg binding to each gene in
the metaproﬁles. Genes with more than one RXRa–RARg binding site appear several times; genes in red are validated by ChIP–qPCR and reChIP–qPCR in (D, E).
(C) Examples of ChIP-seq proﬁles per class. RXRa (red) and RARg (blue) proﬁles are overlaid and depicted per time point. Heatmaps in the right display P-value
conﬁdence as in (B). (D) ChIP–qPCR validation of RXRa and RARg binding depicted as fold occupancies relative to a ‘cold’ region. (E) ReChIPs to assess co-binding
of RXRa with RARg (black line) or RARa (dashed line).
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of RXRa and RARg at 48h which correlated with late RAC3
and p300 co-activator recruitment and late gene induction.
The RXRa–RARg co-occupancy of these binding sites at
different time points was conﬁrmed by reChIP assays
(Figure 3E). In summary, the spatio-temporal cross-compar-
ison between RXRa–RARg binding and transcriptional activa-
tion revealed the existence of at least four different gene
classes with distinct temporal inductions.
The putative RXRa–RARc target genes contain a
subset of promiscuously regulated genes that
respond to other RAR isotypes
To assess the selectivity and promiscuity of RAR isotype
signalling the use of isotype-selective ligands (de Lera et al,
2007) in the context of wild-type cells appeared to us superior
to the use of RAR isotype-deﬁcient cells, as such cells may
exhibit artifactual ligand responses (Chiba et al, 1997a,b).
To reveal RAR isoform-selective transcription of putative
RXRa–RARg target genes, we thus used the RARg-selective
ligand BMS961. Notably BMS961, which sufﬁces to drive F9
cellsintodifferentiation(Tanejaetal,1996;seeSupplementary
FigureS5AandB),activated 62%oftheATRA-inducedputative
RXRa–RARg targets (Figure 4). The RARa or RARb-selective
BMS753 and BMS641, which do not induce F9 differentiation
(Taneja et al, 1996 and our unpublished results), still activated
40 and 10%, respectively, of the ATRA-induced transcrip-
tome, thus providing evidence for both RARg selectivity and
RAR isotype promiscuity of RXRa–RARg target genes in the
context of F9 wild-type cells. That 38% of the ATRA-induced
RARg–RXRa target genes were not activated by BMS961
indicates that they are not required for F9 cell differentia-
tion according to generally used criteria (Supplementary
Figure S5). Mechanistically, these genes may be activated
through direct or indirect action of RARa and/or RARb
isotypes. Possible scenarios are that both RARg and RARa
or RARb heterodimers sequentially or coordinately bind to
their regulatory regions, or that RARa or RARb activate factors
that synergize with RARg action.
A dynamic regulatory map for ATRA-induced F9
cell differentiation
The above results reveal that the putative RXRa–RARg gene
program sufﬁces to trigger primitive endodermal F9 cell
differentiation. It is reasonable to assume a hierarchical
architecture of this program in that a few key genes coordinate
cascades of gene-regulatory events thus establishing subpro-
gramnetworks.Indeed, theinduction ofmultiple TFssupports
a concept in which regulatory decisions are taken, albeit
not exclusively, through TF action at deﬁned time points.
To identify these decisions, we used ATRA-induced temporal
gene expression, TF-target gene annotations (NCBI database
annotations and/or MatInspector predictions; Cartharius et al,
2005) and the identiﬁed putative RXRa–RARg target genes
as input into the Dynamic Regulatory Events Miner (DREM;
Ernst et al, 2007). DREM models bifurcation points (BPs) from
the expression of a subset of genes that diverges from the
co-expression pattern shared with a larger population in the
previous time frame. In addition, DREM evaluates if a co-
expression path is enriched for genes regulated by particular
TFs whose action may account for, or contribute to the
predicted bifurcation. DREM predicted six different co-expres-
sion paths from three BPs (Figure 5A). The ﬁrst BP occurs
between 0 and 2h and results in the establishment of three
distinct programs generating induced (orange), constitutive
(grey or path (iv); this class gets induced late) and repressed
(red) cohorts. The second BP subdivides the repressed path
between 2 and 6h. It separates one cohort that is progressively
induced between 24 and 48h (path (v)) from a permanently
repressed gene set (path (vi)). A third BP between 6 and 24h
derives three cohorts from the induced path; one that gets
repressed (path (iii)) and two others that are induced with
different kinetics and mean intensities (paths (i) and (ii)).
To support the validity of the predicted co-expression paths,
the three gene sets originating from the ﬁrst BP were classiﬁed
by hierarchical clustering. As shown in Figure 5B, each of
these subsets clustered into cohorts predicted by the second
and third BP, with the exception of related paths (i) and (ii)
which appear as one class.
One of the advantages of DREM is the possibility to derive
associations between TFs and predicted BPs. In agreement
with results described above (Figures 2A and 3), DREM
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(i) and (ii). In addition, target genes of TF-like members of
the Homeobox family (e.g., Hoxa1, Hoxb2, Hoxb4, Hoxb5),
Myc, Rara, Rarb, Runx1, Jun, Foxa2, Gata4, Pbx1 were also
predicted to be enriched in these cohorts (see Supple-
mentary Figure S6 for TF enrichment scores). Note that
the repressed path (vi) is associated with TFs like Egr1
(Min et al, 2008) and Sox2 (Orkin et al, 2008), which are
involved in regulating cell proliferation and stem cell pluri-
potency, respectively.
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RXRa–RARg regulon is further illustrated by the temporally
regulated expression of TFs themselves (Figure 5C; Supple-
mentary Figure S6B). Indeed, with the exception of genes like
Sox2, the majority of TFs are generally induced. Of interest
is the biphasic response of Egr1 and Myc, which together
with Sox2, is associated with class (vi) genes. Egr1 and
Myc are induced when paths (v) and (vi) separate and get
silenced between 6 and 24h. This suggests that not only
enhanced transcriptional activity but also temporally regu-
lated expression of TFs contributes to the formation of
temporal gene programs.
To validate the role of DREM-predicted TFs involved in
BPs, we performed small interference RNA (siRNA) knock-
down assays using as readout the mRNA expression of
differentiation markers Laminin a1 (Lama1), Laminin b1
(Lamb1), Laminin g1 (Lamc1), type IV collagen a1 (Col4a1);
in addition, we monitored siRNA effects on the morpho-
logical changes associated with differentiation (Figure 5E–G).
We also knocked down expression of Foxa1, a TF that is not
predicted by DREM but is strongly and exclusively induced
by ATRA and BMS961 (Figure 2C; Supplementary Figure S8;
class I). Knockdown of Hoxb2, Hoxb5, Foxa1 or Foxa2 (see
Supplementary Figure S7A for silencing efﬁciencies) reduced
signiﬁcantly the differentiation marker expression levels
(Figure 5E). Notably, the expression levels of Nostrin, a late
induced direct RXRa–RARg target, Bmp2, an established
RA target or GAPDH were not, or only marginally affected
(Supplementary Figure S7B). Tracking transfection with ﬂuo-
rescent 6-FAM revealed that transfected cells were generally
delayed (or arrested) in differentiation, while non-transfected
cells within the same population exhibited a differentiated
morphology (Figure 5F). Counting of blinded samples by
two independent persons provided a semiquantitative analy-
sis (Figure 5G), which fully supports the notion that these
TFs have important roles in the (temporal) regulation of
gene networks that are at the basis of ATRA-induced cell
differentiation.
The dynamic map derived by DREM classiﬁed the differen-
tially regulated genes during cell differentiation in six major
paths, which can be distinguished by the relative enrichment
of their components according to Gene ontology (GO) terms
(Figure 5D; Supplementary Figure S8). Indeed, while the early
and sustained induced paths (i) and (ii) are enriched for genes
related to embryonic morphogenesis and actin cytoskeleton
organization, respectively, the early temporally induced path
(iii) is enriched for genes involved in steroid/cholesterol
metabolic processes. The late induced path (iv) is associated
with cell adhesion, positive regulation in response to external
stimuli while path (v) is linked to cell-cycle regulation.
Interestingly, the repressive path (vi) is enriched for genes
that negatively regulate cell differentiation.
A comprehensive ATRA-induced RXRa–RARc
signalling network
With the aim of enhancing the dynamic landscape of the
RXRa–RARg regulome inferred by DREM, we reconstructed
the corresponding gene networks on the basis of functional
co-citation (Genomatix Bibiosphere PathwayEdition) and the
identiﬁcation of essential nodes by topology-based scoring
methods (cytoHubba; Lin et al, 2008). The illustration of the
resulting RXRa–RARg regulome (Figure 6; Supplementary File
S1) depicts the relevant components of the six co-expression
classes (compare Figure 5) and speciﬁes their intraclass and
interclass co-citation interactions.
Several general features can be extracted from this dynamic
network of co-expression classes. First, each class is unique in
expressing a particular set of genes with similar general
functionality, such as the TF-rich class (i). Second, genes
regulating complex biological phenomena may appear in
different classes with distinct expression proﬁles, as the
subsequent inductions of cyclins and cyclin-dependent kinase
inhibitors. Third, the present ChIP-seq data identify putative
RAREsinagreatnumberofgenes,someofwhichareknownto
respond to retinoids (see Supplementary Table I). Fourth, the
described F9 RXRa–RARg regulome integrates several factors
with important roles in other cell systems, such as Egr1 and
Notch4. Fifth, comparing regulation of the putative target
genes by subtype-selective ligands reveals RAR subtype
selectivity and promiscuity; moreover, the subset of genes
commonly regulated by ATRA and BMS961 which are
divergently regulated by RARa and RARb ligands is likely
constitute the bona ﬁde differentiation program.
Within class (i), topology-based scoring identiﬁed Jun, Myc,
Rara or Rarb as most important nodes. While the positive
regulation of Jun and Myc expression by ATRA has been
described (Supplementary Table I) the biphasic expression
seen upon ATRA exposure is not maintained with the
RARg-selective BMS961 (Supplementary Figure S6B). Indeed,
BMS961 only recapitulates the early and late downregula-
tion of the expression of Jun and Myc, respectively. Thus,
the temporally regulated repression but not the induced
Figure 5 Dynamic regulatory map of ATRA-induced transcriptome. (A) DREM co-expression analysis is represented by colour-coded paths that summarize common
characteristics. The number of genes per co-expression path is indicated. Diamonds indicate three predicted bifurcation points (BP1–3); transcription factors (TFs)
whose target genes are overenriched in a path are indicated. Node’s size reﬂects the genes’ expression standard deviation assigned to that node. (B) Classiﬁcation of
genes associated with the three paths generated by BP1, by hierarchical clustering of the corresponding temporal transcriptomics data leads to the subclassiﬁcations
predicted by BP2 and BP3. (C) Transcriptional regulation of TFs associated with BP decisions. (D) Relevant Gene Ontology terms associated with each co-expression
path. (E) mRNA expression levels of Laminin a1 (Lama1), Laminin b1 (Lamb1), Laminin g1 (Lamc1), type IV collagen a1 (Col4a1) in F9 cells transfected with siRNA
constructs against TFs associated with BP3 or against Foxa1, a TF induced exclusively by ATRA and BMS961. Expression levels correspond to the mean of three
replicates and are displayed relative to those found in GFP-control siRNA-transfected cells. (F) Morphology of siRNA-transfected cells 48h after ATRA treatment.
Transfected cells are identiﬁed by ﬂuorescence from co-transfected FAM. Top panels: Hoxb2 or Foxa1 siRNA-transfected ATRA-treated cells. Bottom panels: mock-
transfected vehicle-exposed undifferentiated cells and GFP siRNA-transfected ATRA-treated cells, respectively. Note that in the case of Hoxb2 or Foxa1, transfected
(ﬂuorescent)cellsarelessdifferentiatedthanadjacentnon-transfectedcells(bar¼25mm).(G)Blindedsemiquantiﬁcationcorrelatingmorphologicaldifferentiationstatus
and FAM-derived ﬂuorescence by cell counting; data are the mean of two independent blinded quantiﬁcations.
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Multiple other TFs contribute to the deﬁnition of class (i).
Apart from two other RAR isotypes, there is a strong repre-
sentation of members of the homeobox TF family, including
Cdx1, Meis2, some of which have well-characterized RAREs
(Supplementary Table I) and served as validation marks
for our ChIP-seqs. Finally, Foxa1 and two NR co-regulators
(Ncoa7 and Nrip1) are putative regulatory factors of class (i).
In addition to TFs, this class contains also RA-target genes
involved in retinoid homeostasis, including Cyp26a1, Crabp2
or Rbp1. Importantly, all of these genes are similarly regu-
lated by ATRA and BMS961 but not by BMS753 or BMS641
(Supplementary Figure S9), thus supporting a functional role
in F9 cell differentiation.
According to GO terms, class (i) is predicted to trigger
positive regulation of transcription, cell differentiation and
responses to vitamin A. Class (ii), which shares a common
ancestor with classes (i) and (iii), is characterized by the
enrichment of genes involved in actin cytoskeleton organiza-
tion (Supplementary Figure S8). This cohort contains also
several apoptogenic factors, including Casp3, Casp8, Bcl2l11
and Mcl1, and the signalling factors Jak2, Rhob and Pim;
several of these genes are known to respond to retinoids
(Supplementary Table I). Comparing the induction proﬁles of
these genes by the three RAR subtype-selective agonists
indicates that their ATRA regulation may not be directly linked
toF9differentiation;examplesforthisnotionareId2,Casp3or
Pim1 (see class (ii) in Supplementary Figure S9).
Several genes that are components of a similar biological
process are found in different classes and it is tempting to
speculate that this may be linked to their distinct temporal role
during the differentiation process.For instance, the temporally
Node’s Raking score for shortest path identified using
topology-based scoring methods (DSS)
ATRA responsive genes BMS-961/ATRA responsive genes  TF
(i)
(iii)
(ii)
(iv)
(vi)
(v)
Figure 6 A comprehensive ATRA-RXRa/RARg signalling network. Genes associated with the different co-expression paths illustrated in Figure 5 are represented in
the context of their functional gene co-citation interactions. For simplicity, only the top 100 hubs (coloured nodes) and their ﬁrst neighbours (white nodes) are shown.
Edge’s widths correspond to the number of co-citations (limit X5) described between nodes. Hub sizes and colours give the node’s ranking based on topology scoring
(double screening scheme of Hubba; Lin et al, 2008). This network is available in a Cytoscape format in Supplementary File S1.
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differentiation can be rationalized from their functionalities;
while Ccnd2 (class (ii)) expression increases, the class (iii)
genes Ccnd1, Ccnd3 and Ccne1 are only transiently induced
and regress with the expression of ‘late’ class (v) genes p27/
Cdkn1b, p21/Cdkn1a and p57/Cdkn1c, which were repressed
atearlier timepoints.Notethat theseobservationscorroborate
previous reports showing that also the protein levels of cyclin
D2 and p27/Cdkn1b increased during F9 cell differentiation,
whereas that of cyclin D1, D3 and cyclin E decreased (Li et al,
2004).
In addition to cell cycle-regulatory components, class (iii)
contains also genes like Egr1 and Notch4. The ATRA-
responsive Egr1 (Edwards et al, 1991) is sufﬁcient to inhibit
cell proliferationof haematopoietic stem cells (Min et al, 2008)
where Notch4 negatively regulates cell differentiation (Vercau-
teren and Sutherland, 2004; Ye et al, 2004). Note the temporal
binding of RXRa–RARg to the Notch4 promoter region in F9
cells, which correlates with its transient mRNA expression
(Figure 3).
The ‘late’ class (iv) comprises genes involved in processes
like extracellular matrix organization (Col18a1, Sparc, Timp3)
or cell adhesion (Cd9, Cd47, Nedd9, Cdh2, Thbs1, Sirpa, Cdh5,
Cyr61, Cdh11). These gene regulations are likely readouts of
the morphological changes associated with differentiation,
supported by the fact that RARa or RARb-speciﬁc agonists do
not induce a similar expression as ATRA or RARg-speciﬁc
agonists (Supplementary Figure S9). Also, late induced TFs
like Foxa2/HNF-3, Runx1 and the TF-related factor Zmiz1 are
members of this class (Supplementary Table I). Finally,
germline-speciﬁc differentiation markers, like Otx2 and Fgf4
for ectodermal or Bmp2, Gata4 and Hnf1b for endodermal
differentiation were retrieved in classes (iv) and (vi) for which
their temporal transcription pattern correlates with differen-
tiation into primitive endoderm (Supplementary Figure S9).
Taken together, the comprehensive co-expression network,
reconstructed from an integrative analysis of RXRa–RARg
binding and transcription regulation, illustrates the complex
temporal coordination of a plethora of molecular processes
during differentiation, including cell-cycle regulation, the
activation of apoptotic/cell survival or repression of self-
renewal/pluripotency.
Discussion
NR-regulated cell physiological phenomena, such as differ-
entiation, growth, survival or death, are at the basis of
complexphysiological processes. Despite an enormous gain of
knowledge about molecular and structural features of NR
function (Perissi and Rosenfeld, 2005; Altucci et al, 2007;
O’Malley and Kumar, 2009), we are still far from under-
standing of how a single compound, such ATRA, can induce
temporal patterns of coordinate regulation of gene networks
that ﬁnally lead to the observed changes of cell, organ or
animal physiology. With the availability of a number of
genome-wide proﬁling technologies, it is now feasible to
initiate integrative analyses to decipher the gene-regulatory
phenomena and describe the dynamic regulation of gene
networks. To this aim, we have used the ATRA-induced F9 EC
cell differentiation model and describe to our knowledge the
ﬁrst dynamic analysis of the RXRa–RARg regulon by an
integrative analysis of genome-wide temporal binding of the
RXRa–RARg heterodimer, the corresponding temporal gene
regulation patterns and the response to subtype-selective RAR
agonists. Our aim was to understand signal diversiﬁcation and
speciﬁcation at different functional levels, ranging from the
speciﬁc action of RAR subtypes to decisions within the process
of differentiation that result in the formation of separate gene
programs and ﬁnally to the description of the key components
therein which may provide clues to the program function(s).
One of the unexpected outcomes of this analysis is the
astounding dynamics of RXRa–RARg binding. It was recently
shown that ATRA-induced differentiation of mouse ES cells to
motor neurons results in widespread changes in RAR genomic
binding(Mahonyetal,2011).Thisdocumentedthatincontrast
to the apooestrogenreceptor, which binds to a limitednumber
of target sites and acquires extensive chromatin binding
capacity in presence of agonists (Carroll et al, 2005, 2006;
Ceschinetal,2011),apoRARalreadybindstoalargenumberof
sites (some of) which it may silence by recruiting corepressor
complexes. On the other hand, ligand exposure was shown to
generate de novo RAR binding to certain target genes (Chen
et al, 1996). Our present data not only conﬁrm those studies at
the genome-wide level but also demonstrate, moreover, a
precise temporal order of gain and loss of binding sites for a
particular RXR–RAR heterodimer during the ﬁrst 48h of
differentiation. We observed an unexpected ﬂuctuation of
different RXRa heterodimers at sites initially occupied by
RXRa–RARg. Two interesting scenarios could account for this
phenomenon, replacement of RXRa–RARg by another RXRa
heterodimer or swapping of RXRa partners. This temporal
orderof binding of different RAR heterodimersto the same site
is supported by the observations (i) that reChIP experiments
reveal a temporally distinct co-binding of RARg and RARa
together with RXRa to the Rarb RARE (Figure 1E and F) and
(ii) that a signiﬁcant number of putative RXRa–RARg target
genes respond not only to RARg-selective but also to RARb
and/or RARa-selective ligands (Figure 4; Supplementary
Figure S9). Taken together, our analysis of RXR–RAR binding
reveals a highly dynamic occupancy of its target loci suggesting
the existence of mechanism(s) that orchestrate in a clock-
like manner the sequential recruitment and release of RXR
heterodimers. It is tempting to speculate that site-selective
chromatin modiﬁcations have a role in this process, which
may involve previously observed histone methyltransferase
and demethylase gatekeepers (Garcia-Bassets et al, 2007).
Such mechanism(s) may also account for the absence of
temporal correlation between heterodimer binding and gene
activation. Indeed, the presence of RXRa–RARg localization
preceded in certain cases by several hours the transcription
induction, indicating that holoRXRa–RARg binding is not
per se sufﬁcient for transcription induction; inversely, the
dissociationofRXRa–RARgdoesnotnecessarilycorrelatewith
attenuated transcription. Due to this lack of temporal correla-
tion the generation of metaproﬁles from different time points
facilitated the comparison with temporal gene regulation.
The observation that distinct RAR subtype heterodimers
can bind at identical target sites complicates the deﬁnition of
subtype-selectivetargetgenerepertoires.Asit hasbeen shown
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responses (Chiba et al, 1997a,b), and affect global gene
expression proﬁling even in absence of any treatment (Su and
Gudas, 2008), we used RAR subtype-selective agonists (Gehin
et al, 1999; Germain et al, 2004; de Lera et al, 2007) to deﬁne
selective and promiscuous functionalities of RAR subtypes.
Notably, the RARg-speciﬁc agonist BMS961, which is compe-
tent to induce F9 cell differentiation, activated 460% of the
putative RXRa–RARg target genes, thus conﬁrming a causal
link between binding and transcription activation for this
cohort. While our analysis identiﬁed the RARg-selective gene
program for F9 cell differentiation and revealed RAR subtype
promiscuity, deﬁnition of the complete program will require
the target site identiﬁcation of the great number of binding
sites that could not be linked to annotated genes.
To approach an understanding of the decisions that lead
to the establishment of subprograms, we used DREM for the
in silico reconstruction of a dynamic regulatory map. This
approach was supported by the observation that multiple TF
were among the genes regulated by ATRA and BMS961. DREM
analysis predicted six different gene co-expression paths,
whichresultfromthreedistinctbifurcationsduringtheﬁrst6h
of ATRA treatment. Note that this is the time span required for
differentiation commitment (Levine et al, 1984). Some of the
TFs associated with the DREM-predicted gene co-expression
pathswereshownheretohaveanimportantroleduringF9cell
differentiation (Figure 5E–G; Supplementary Figure S7),
others were described previously (Gata4, Futaki et al, 2004;
Sox2, Chew et al, 2005; Boer et al, 2007).
To gain insight into the functionality of the co-expression
gene cohorts and identify key players, we established a
dynamic regulatory map and constructed a differentiation-
related gene network from functional co-citation. While not
exhaustive, this RXRa–RARg driven dynamic network pro-
vides a global view on the regulatory events during ATRA-
induced F9 cell differentiation. Indeed, genes associated with
each class were shown to share similar general functions and
genes of distinct classes displayed a coordinate temporal order
ofexpressionthatisrequisiteforregulatingcomplexbiological
phenomena. That an important number of RXRa–RARg target
genes did not show up in the reconstructed network is due to
their original identiﬁcation in the present study, accounting
for the lack of co-citation. It is worth pointing out that a
comparison of gene regulation by subtype-selective ligands,
as illustrated in the reconstructed network, was useful to
validate their importance for differentiation and discover RAR
subtype promiscuity.
Overall, the current study illustrates for the F9 model the
different levels of ATRA-induced signalling pathway diversiﬁ-
cation due to regulatory decisions at different levels and time
points. Whereas other regulatory principles, like the chroma-
tin modiﬁcation status and co-regulator function and mod-
iﬁcation (Ceschin et al, 2011) may be overlaid at any of these
levels, the current gene network identiﬁes potential nodes that
act as key regulators of various subprograms of RA-initiated
signal transduction during differentiation. It will be interesting
to integrate other RXR–RAR components and compare other
RA-regulated cell models to retrieve common and cell-speciﬁc
features.Ultimately, itmaybe possible topredictcriticalnodes
from applying computational models to reconstructed gene
networks (Fisher and Piterman, 2010) and extrapolate this
information towards other model systems that mimic RAR-
dysfunctional human diseases (Gronemeyer and Zelent, 2009;
Mikesch et al, 2010), as targetable key factors for therapy.
Materials and methods
F9 mouse EC cell culture
EC cells were cultured in Dulbecco’s modiﬁed Eagle’s medium
supplemented with 10% fetal calf serum and 40mg/ml Gentamicin.
Cells were seeded in gelatine-coated tissue culture plates (0.1%) and
ATRA was added to the plates in a ﬁnal concentration of 1 10
 6 M
at different time points. For assays involving RAR subtype-speciﬁc
agonists, cells were incubated with BMS961 (RARg speciﬁc; ﬁnal
concentration 10
 7 M), BMS753 (RARa speciﬁc; ﬁnal concentration
10
 6 M) or BMS641 (RARb speciﬁc; ﬁnal concentration 10
 6 M).
ChIP and reChIP assays
Cells were ﬁxed with 1% para-formaldehyde (Electron Microscopy
Sciences) for 30min at room temperature. ChIP assays were per-
formed following standard conditions: chromatin sonication and
immunoprecipitation in lysis buffer (50mM Tris–Cl pH¼8, 140mM
NaCl, 1mM EDTA, 1% Triton, 0.1% Na-deoxycholate) complemented
with protease inhibitor cocktail (Roche 11873580001); 2  washes
with lysis buffer; 2  washes with lysis buffer containing 360mM
NaCl; 2  washes with washing buffer (10mM Tris–Cl pH¼8, 250mM
LiCl, 0.5% NP-40, 1mM EDTA, 0.5% Na-deoxycholate); 2  washes
with 1  TE; elution at 651C; 15min in elution buffer (50mM Tris–Cl
pH¼8, 10mM EDTA, 1% SDS). RXRa and RARg have been immuno-
precipitated with antibodies generated by immunization of rabbits
with the following peptides:
mRXRa: PB105 (MDTKHFLPLDFSTQVNSSSLNSPTGRGC),
mRARg: PB288 (CSKPGPHPKASSEDEAPGGQGKRGQSPQPD).
Polyclonal anti-RXRa and anti-RARg were puriﬁed from the crude
serumbyafﬁnitychromatography.RNAPolymeraseII(sc-9001H-224),
p300 (sc-584 N-15) and Rac3/NCoA-3 (sc-9119) antibodies were pur-
chased from Santa Cruz biotechnology (Santa Cruz, CA). For RXRa,
RARg, p300 and RAC3 6 10
6 cells were used per ChIP, whereas for
RNApolII2 10
6cellswereused.ForreChIPs,atleastfourChIPassays
of 6 10
6 cells were used for the ﬁrst IP. For reChIPs, the ﬁrst antibody
(anti-RXRa) was covalently linked to the sepharose protein A (Sigma
P92424) using disuccinimidyl suberate (DSS). The covalently linked
Ab beads were washed with ethanolamine (0.1M), followed by glycin
at pH¼2.8 to removenon-covalently linked antibodiesfrom the beads.
Beads were washed with 50mM sodium borate at pH¼8.2 and PBS,
and were incubated overnight at 41C with the corresponding whole
cell extract as in a regular ChIP assay. Following standard washing,
elution was performed with 10mM DTT (30min, 371C). The eluates
from four ChIPs were combined, diluted at least 30 times with lysis
buffer (containing protease inhibitors like in a regular ChIP assay),
and incubated overnight with the second antibody (anti-RARg) and
sepharose ProteinA beads at 41C. The subsequent stepswere performed
as for regular ChIPs.
The immunoprecipitated chromatin was validated using positive
(recruitment to known targets) and negative (‘cold’ region) controls
and the binding was expressed as enrichment relative to the whole
cell extract input control (% input) and/or relative to a ‘cold’ region
(fold occupancy); validation assays were performed by quantita-
tive real-time PCR (qPCR, Roche LC480 light cycler device) using
Quantitect (Qiagen).
Massive parallel sequencing
After qPCR validation, immunoprecipitated chromatin was quantiﬁed
using Qubit (Quant-It dsDNA HSAssay Kit; Invitrogen). In all, 10ng of
the ChIPed material was used for preparing the sequencing library
(ChIP-seq DNA sample preparation kit, Illumina). In all, 5pmol of the
library was used per ﬂow cell in the Solexa 2G Genome analyzer
Dissecting RA-induced differentiation of F9 embryonal stem cells
MA Mendoza-Parra et al
12 Molecular Systems Biology 2011 & 2011 EMBO and Macmillan Publishers Limited(Illumina). The Illumina Pipeline v1.4.0 was used for primary data
analysis(imageprocessing:Firecrest;basecalling:Bustard;alignment:
Gerald) fromwhichuniquelyalignedreadswithupto two mismatches
relative to the mouse mm9 reference genome were kept.
Peak detection approach
MACS v. 1.3.6 (Zhang et al, 2008) was used as peak caller at the ﬁrst
level of data treatment to obtain signal intensity wiggle ﬁles and
annotated peak regions using a Poisson model distribution (P-value
conﬁdence cutoff:1 10
 5). Consideringthat acertainnumberoffalse
positive regions were observed during this treatment, which in our
hands cannot be decreases without compromising true positives by
playing with the P-value conﬁdence parameter, we used subsequently
an approach based on a machine-learning algorithm able to deﬁne the
model distribution associated with the ChIP-seq data set under study.
This approach, implemented in the R package MeDiChI, has been
previously described (Reiss et al, 2008) for analysis of ChIP-chip
assays; its implementation for ChIP-seq assays will be described
elsewhere (manuscript in preparation).
RT–PCR and microarrays
Total RNAwas extractedfromcells,treated with ATRAduringdifferent
period of times, using the GENEElute
TM RNA extraction kit (Sigma).
In all, 2mg of the eluted RNA was used for reverse transcription
(AMV-RTase, Roche; oligo(dT) New England Biolabs; 1h; 421C).
The cDNA was diluted 10-fold and used for real-time qPCR (Roche
LC480). Expression of the following marker genes was assessed to
follow the process of F9 cell differentiation:
For early response to the differentiation inductor (ATRA):
Hoxa1 (CCCAGACGGCTACTTACCAG; CATGGGAGTCGAGAGGTTTC);
Rarb (GATCCTGGATTTCTACACCG; CACTGACGCCATAGTGGTA).
For late response to the differentiation inductor (ATRA):
Col4a1 (ATGCCCTTTCTCTTCTGCAA; ATCCACAGTGAGGACCAACC);
Lama1 (CCGACAACCTCCTCTTCTACC; TCTCCACTGCGAGAAAGTCA);
Lamb1 (TCTATGCTCGGCAGTGTGAC; CAGTGGTCTCCTGACCCAAT);
Lamc1(GGCCGAGTGCCTACAACTT;CAGTGGCAGTTACCCATTCC).
During data analysis, all qPCR values were normalized relative
to the constitutively expressed 36B4 mRNA (AATCTCCAGAGGCACC
ATTG; CCGATCTGCAGACACACACT).
Using 250ng of starting total RNA, biotin-labelled cDNAs were
synthesized and hybridized on Affymetrix GeneChips Mouse Gene
1.0 ST Array (Affymetrix, Santa Clara, CA, USA) according to the
manufacturer’s recommendations as described in ‘GeneChips whole
transcript sense target labelling assay manual’ (P/N 701880 Rev.4).
The arrays were further washed and stained with streptavidine-
phycoerythrin in an Affymetrix GeneChips Fluidics station 450
using the script protocol F450-0007, then scanned with an Affymetrix
Gene Chip Scanner 3000 7G. Expression values were generated with
Affymetrix software Expression Console version 1.1, using sketch
quantile normalization and median polish summarization as in
Robust Multiarray Analysis.
RNA polymerase II ChIP-seq data processing
RNA Polymerase II genome-wide intensity proﬁles were generated
using MACS v. 1.3.6 (Zhang et al, 2008) as peak caller and signal
intensity proﬁles were processed by MeDiChI to identify chromatin
regions presenting signiﬁcant RNA Polymerase II enrichment (P-value
cutoff: 1 10
 2). MeDiChI-predicted enriched regions were further
ﬁltered according to their genomic localization by comparing them
with the mm9 coding region Ref-seq annotation. Thereby coding
regions presenting signiﬁcant levels of RNA PolII at the TSS were
identiﬁed and selected for further analysis. A Quantile normalization
procedure was used to enable a comparison between different
samples. Normalized proﬁles were compared in the context of their
signal intensities to identify local changes in the Pol II occupancy
relative to the control sample. Note that this approach differs from
previously described linear corrections between samples based on
total numbers of reads; it has been implemented in the R package
POLYPHEMUS (Mendoza et al, submitted). The ﬁnal comparisons
between the PolII levels at the TSS relative to the average behaviour
through the gene body have been used as readouts to identify and
describe genes presenting an enhancement of their transcriptional
activity at the different analysed time points (Figure 2).
Data integration
The global RXRa and RARg localization at different time points during
ATRA-induced differentiation has been followed by ChIP-seq. To
increase the conﬁdence in binding localization assessment, we
collected the mappable reads from all ﬁve time points in a single ﬁle
called metaproﬁle. The metaproﬁle associated with the localization of
RXRa and RARg was processed by MACS and MeDiChI to identify
signiﬁcant enriched regions. Interestingly, this approach generates a
higher signal/background contrast, thus increasing the sensitivity of
peak calling. Taking in consideration the heterodimeric nature
between RXRa and RARg, we compared the two metaproﬁles to
identify the optimal conﬁdence parameter at which the coexistence
between RXRa and RARg is maximal (see Figure 1A). Indeed, for a P-
value threshold of 1 10
 4 (CT40; where CT¼ 10   log (P-value)) all
identiﬁed RARg sites in the metaproﬁle colocalize with RXRa. These
co-occupied sites were further evaluated in the context of their
temporal RXRa and RARg co-occupancy. Whereas a CT40 has been
used for metaproﬁles binding sites selection, the same parameters are
too stringent for the analysis of time-point proﬁles. We have taken a
CT25 per time-point proﬁle for evaluating the RXRa and/or RARg
occupancy at the pre-identiﬁed sites (Figure 1B).
RXRa–RARg co-occupied sites (metaproﬁles comparison) were
annotated based on their proximity (o10kb) to transcriptionally
activecodingregions(upregulationanddownregulationlevelsrelative
to control sample: ratio cutoff X1.8 and p0.5, respectively);
annotated genes are referred to as ‘putative’ target genes. In order to
gain temporal information about the correlation between RXRa–RARg
binding and putative target gene transcription, the RXRa and RARg
binding at a given time point was compared with the temporal mRNA
levels of putative target genes. To further remove possible false posi-
tive annotations, genes presenting coexistence between RXRa–RARg
binding and differential mRNA expression levels at least at one time
point were retained during selection. For classiﬁcation purposes, the
coexistence of several events was scored per time point following a
hierarchical order of importance in the context of gene regulation:
Finally, the temporal incidence of the evaluated events was
classiﬁed using an SOTA approach (Euclidean distance, Max.
cycles¼7, cell variability P-value¼0.01) under the open access
multiExperiment Viewer (Saeed et al, 2003, 2006; see Figure 3).
Dynamic regulatory maps and Network
reconstruction
RXRa–RARg putative target gene information as well as further TF-
gene regulatory interaction annotations extracted from the NCBI
database and/or predicted by MatInspector (Cartharius et al, 2005)
were combinedinto abinarymatrix(‘1’for TF-targetgeneassociation;
otherwise ‘0’). Furthermore, time-point transcriptomics data were
Evaluated event Score
—0
RXRa 1
RARg 2
RXRa; RARg 3
Gene induction 4
RXRa; gene induction 5
RARg; gene induction 6
RXRa; RARg; gene induction 7
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sets were integrated into the DREM (Ernst et al, 2007) to establish
dynamic regulatory maps. In addition to classifying temporal sets of
gene expression data into co-expression paths, DREM predicts BPs,
deﬁned as a time point at which the co-expression behaviour of a
subset of genes diverges from the common path present in a previ-
ous time point. Moreover, the association of a given TF with the
corresponding BPs is estimated by evaluating the enrichment of its
target genes using hypergeometric distributions relative to the genes
associated with the common path.
To construct gene networks, genes associated with each predicted
co-expressionpathwereevaluatedinthecontextoftheirfunctionalco-
citation relationships (Genomatix Bibiosphere PathwayEdition). To
identify functional co-citation interactions between different co-
expression paths, all genes used for the initial analysis were evaluated
for their functional co-citations relationships as explained before.
Finally, the intra- and inter-co-expression paths co-citation interac-
tions were integrated into Cytoscape (Shannon et al, 2003; Cline et al,
2007).Tofurtherincreasetheconﬁdenceofthereconstructednetwork,
topological information concerning the number of edges per node
(Hubba; Lin et al, 2008) were used as ﬁlter in the ﬁnal representation.
Brieﬂy, we have used Hubba’s Double screening scheme (DSS)
approach, which combines a Maximum Neighbourhood Component
(MNC) with a Density of Maximum Neighbourhood Component
(DMNC)toscorenodesbasedonthenumberoftheirinterconnections.
The ﬁnal gene-network representation corresponds to the top 100
ranked nodes (red to green colour code) as well as their corresponding
ﬁrst level neighbours. Additional information, like TF annotations,
BMS961 and ATRA responsiveness, number of functional co-citations
between nodes (edge’s broadness) and co-expression path belonging
(colourcoded)arealsoincludedintheﬁnaldisplayofthisRXRa–RARg
induced genes network, which is also available in Cytoscape format
(Supplementary File S1). Transcriptomics data associated with ATRA
and RAR subtype-speciﬁc agonist treatments were also included as
attributes for the reconstructed network (Supplementary Files S2–S6).
siRNA transfections
F9 cells were transfected with siRNA oligomers directed against
RNA target sequences for the following TFs: Hoxb2 (QIAGEN;
FlexiTube GeneSolution: Cat. No. SI01069089, SI01069096, SI01069075,
SI01069082; working concentration: 50nM); Hoxb5 (QIAGEN; FlexiTube
GeneSolution: Cat. No. SI01069173, SI01069180, SI01069159, SI01069166;
working concentration: 50nM); Foxa1 (QIAGEN; FlexiTube GeneSolution:
Cat. No. SI01004493, SI01004500, SI01004479, SI01004486; working
concentration: 50nM); Foxa2 (QIAGEN; FlexiTube GeneSolution:
Cat. No. SI01004528, SI02737182, SI01004514, SI01004521; working
concentration: 50nM); Gata4 (QIAGEN; FlexiTube GeneSolution:
Cat. No. SI01009813, SI01009820, SI01009799, SI01009806; working
concentration: 50nM). In addition, F9 cells were transfected with an
siRNA oligomer directed against the RNA target sequence of GFP
(Dharmacon; P-002048-01-20; working concentration: 50nM) as a
control for the speciﬁcity of the assay. The transfection efﬁciency has
been followed by co-transfecting the previous oligomers with the
6-FAM labelled siGLO transfection indicator (Dharmacon; D-001630-
01-05; working concentration: 50nM). F9 cells were transfected with
Lipofectamine 2000 (Invitrogen; Cat. No. 11668-027) during 18h, then
medium has been changed and cells were treated either with ATRA
or with ethanol during 48h as previously described.
Data access
Affymetrix microarrays as well as Illumina platform ChIP-seq data
described in this study are available from the Gene Expression
Omnibusdatabase(http://www.ncbi.nlm.nih.gov/geo) underaccession
number GSE30539.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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